Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Allergy & Immunology
•
Asthma
Do you utilize urinary leukotrienes as a marker for initiation of montelukast?
Answer from: at Academic Institution
No, I don’t. It is not readily available clinically and has not been shown to be predictive of response.
Sign in or Register to read more
23597
Related Questions
What is the rationale/evidence to support doing 4 puffs of albuterol vs. 2 puffs for a reversibility study?
Can a biopsy finding of eosinophilia in the gut (esophagus, stomach, duodenum) be reactive in the setting of Crohn's disease or due to anti-TNF blockade?
Is there any genetic testing available for the CDHR3 receptor?
What is your approach to distinguishing a Jarisch-Herxheimer reaction from a delayed anaphylactoid reaction?
Has anyone incidentally diagnosed IgA deficiency in a patient who does not present with any recurrent infections?
Should in-office oscillometry for lung function measurements be utilized in pediatric patients who are unable to reliably perform spirometry?
How would you approach an asymptomatic older female patient with eosinophilia to 17,000, present for years, and normal eosinophilia workup including marrow and negative FLIP1?
Which patient characteristics or scenarios drive you to choose tezepelumab over dupilumab for asthma?
Is there a role for nitazoxanide for treatment of norovirus gastroenteritis in immunocompromised patients?
Is immunoglobulin replacement an option for CRS in a patient with normal immune function?